AN
Alexandra Nesson
Credentials:
History
- 2024–2027
Residency
- 2020–2024
Medical School
Research
Cancers · 2021 · 34 citations
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Frontiers in Oncology · 2022 · 18 citations
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
Frontiers in Oncology · 2022 · 7 citations
- AS
3 papers

3 papers
- RC
3 papers
- SK
3 papers
- HA
2 papers
- SC
2 papers

1 paper

1 paper


